Prognostic Differences Between VAP from Acinetobacter Baumanii and VAP from Other Microorganisms

Overview

Journal Transl Med UniSa

Date 2013 Aug 2

PMID 23905048

Citations 4

Authors

Marianna Di Bonito

Simona Caiazzo

Marta Iannazzone

Viviana Micciche

Giuseppe De Marco

Edoardo De Robertis

Rosalba Tufano

Ornella Piazza

Affiliations

Soon will be listed here.

Abstract

Nosocomial infection, in particular pneumonia, is an important risk factor for hospital mortality and morbidity. Acinetobacter baumanii is a common multi-resistant microorganism responsible of Ventilator Associated Pneumonia (VAP). Currently Colistin is a rescue therapy for this pathogen. The purpose of this retrospective study is to compare the outcome of VAP caused by Acinetobacter baumanii and VAP from other microorganisms in critical patients. Comorbidity, prognostic scores, mortality and eradication frequency did not turn out significantly different between the two study groups. Colistin safety was tested.

Citing Articles

Effects of the proportion of high-risk patients and control strategies on the prevalence of methicillin-resistant Staphylococcus aureus in an intensive care unit.

Chamchod F, Palittapongarnpim P BMC Infect Dis. 2019; 19(1):1026.

PMID: 31795957 PMC: 6889565. DOI: 10.1186/s12879-019-4632-9.

Specific Gene Loci of Clinical Pseudomonas putida Isolates.

Molina L, Udaondo Z, Duque E, Fernandez M, Bernal P, Roca A PLoS One. 2016; 11(1):e0147478.

PMID: 26820467 PMC: 4731212. DOI: 10.1371/journal.pone.0147478.

Acinetobacter baumannii infection in prior ICU bed occupants is an independent risk factor for subsequent cases of ventilator-associated pneumonia.

Tsakiridou E, Makris D, Daniil Z, Manoulakas E, Chatzipantazi V, Vlachos O Biomed Res Int. 2014; 2014:193516.

PMID: 25101265 PMC: 4101956. DOI: 10.1155/2014/193516.

A translational approach to ventilator associated pneumonia.

Piazza O, Wang X Clin Transl Med. 2014; 3:26.

PMID: 25097729 PMC: 4118201. DOI: 10.1186/2001-1326-3-26.

References

van den Broek P, Arends J, Bernards A, De Brauwer E, Mascini E, Van Der Reijden T . Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin Microbiol Infect. 2006; 12(9):837-43. DOI: 10.1111/j.1469-0691.2006.01510.x. View

Fagon J, Chastre J, HANCE A, Montravers P, Novara A, Gibert C . Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993; 94(3):281-8. DOI: 10.1016/0002-9343(93)90060-3. View

Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G . Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med. 1987; 13(5):342-6. DOI: 10.1007/BF00255791. View

Landman D, Georgescu C, Martin D, Quale J . Polymyxins revisited. Clin Microbiol Rev. 2008; 21(3):449-65. PMC: 2493081. DOI: 10.1128/CMR.00006-08. View

Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J . Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med. 2003; 31(10):2478-82. DOI: 10.1097/01.CCM.0000089936.09573.F3. View

Zarrilli R, Casillo R, Di Popolo A, Tripodi M, Bagattini M, Cuccurullo S . Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clin Microbiol Infect. 2007; 13(5):481-9. DOI: 10.1111/j.1469-0691.2006.01675.x. View

Gaynes R, Edwards J . Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005; 41(6):848-54. DOI: 10.1086/432803. View

Caricato A, Montini L, Bello G, Michetti V, Maviglia R, Bocci M . Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Med. 2009; 35(11):1964-9. DOI: 10.1007/s00134-009-1582-5. View

Cakir Edis E, Hatipoglu O, Tansel O, Sut N . Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents. Ann Thorac Med. 2010; 5(2):92-6. PMC: 2883204. DOI: 10.4103/1817-1737.62472. View

10.

. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32(8):470-85. DOI: 10.1016/S0196655304005425. View

11.

Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez F, Barrero-Almodovar A, Garcia-Garmendia J, Bernabeu-WittelI M . Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003; 36(9):1111-8. DOI: 10.1086/374337. View

12.

Jung J, Park M, Kim S, Hoon Park B, Son J, Kim E . Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis. 2010; 10:228. PMC: 2921386. DOI: 10.1186/1471-2334-10-228. View

13.

Lopez-Rojas R, Dominguez-Herrera J, McConnell M, Docobo-Perez F, Smani Y, Fernandez-Reyes M . Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis. 2011; 203(4):545-8. PMC: 3071218. DOI: 10.1093/infdis/jiq086. View

14.

Johnson E, Burns T, Hayda R, Hospenthal D, Murray C . Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis. 2007; 45(4):409-15. DOI: 10.1086/520029. View

15.

Imberti R, Cusato M, Villani P, Carnevale L, Iotti G, Langer M . Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Chest. 2010; 138(6):1333-9. DOI: 10.1378/chest.10-0463. View

16.

Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z . Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med. 2007; 102(3):407-12. DOI: 10.1016/j.rmed.2007.10.011. View

17.

Trouillet J, Chastre J, Vuagnat A, Joly-Guillou M, Combaux D, Dombret M . Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998; 157(2):531-9. DOI: 10.1164/ajrccm.157.2.9705064. View

18.

Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A, Marquez-Vacaro J . Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 2005; 31(5):649-55. DOI: 10.1007/s00134-005-2598-0. View

19.

Nemec A, Krizova L, Maixnerova M, Diancourt L, van der Reijden T, Brisse S . Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother. 2008; 62(3):484-9. DOI: 10.1093/jac/dkn205. View

20.

. Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1997; 46(RR-1):1-79. View